Although heart disease is the leading cause of death in the United States, a significant portion of people who experience heart attacks are unaware that they have the underlying condition.
Cleerly, a cardiovascular imaging startup, hopes to fix this. By analyzing CT scans of the heart, the company's AI software aims to identify early-stage coronary artery disease, similar to how ...
"Cleerly raises $106m to advance AI imaging platform for heart disease" was originally created and published by Medical Device Network, a GlobalData owned brand.
a significant portion of people who experience heart attacks are unaware that they have the underlying condition. Cleerly, a cardiovascular imaging startup, hopes to fix this. By analyzing CT scans of ...
Cleerly is dedicated to creating a new standard of care for heart disease by utilizing FDA-cleared solutions powered by artificial intelligence. The company's advanced non-invasive computed ...